Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3913 clinical trials
Featured trial
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously

  • 1199 views
  • 21 Apr, 2022
  • 84 locations
Featured trial
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study

  • 0 views
  • 11 May, 2022
  • 20 locations
Featured trial
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early

bradykinesia
tremor
parkinsonism
SPECT Scan
dopamine transporter
  • 99 views
  • 09 May, 2022
  • 109 locations
Featured trial
Study to evaluate HZN-825 in patients with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

The goal is to determine the efficacy, safety and tolerability for 300 patients with Diffuse Cutaneous Systemic Sclerosis (dcSSc) assigned to either one of 2 dose regimens of HZN-825 (administered once daily (QD) or twice daily (BID)), or a placebo regimen for 52 weeks.Participants who complete all study visits may …

  • 0 views
  • 13 May, 2022
  • 22 locations
Featured trial
Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

The main purpose of this study is to examine the efficacy and safety of a repeated dosing ketamine infusion paradigm compared to placebo in individuals with PD.

ketamine
depression
depressive disorder
depressed mood
hoehn and yahr scale
  • 6 views
  • 12 May, 2022
  • 1 location
Featured trial
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

  • 2258 views
  • 23 Nov, 2020
  • 22 locations
Featured trial
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder

The primary objective of the study is to evaluate the efficacy of troriluzole compared to placebo after 8-weeks of treatment in subjects with GAD, as measured by the Hamilton Anxiety Rating Scale (HAM-A) scale  

  • 869 views
  • 10 May, 2019
  • 1 location
Featured trial
A Randomized, Double-Blind, Placebo-Controlled Study of COR388 HCl in Subjects with Alzheimer’s Disease

This is a randomized, double-blind, placebo-controlled study that will assess the efficacy, safety, and tolerability of 2 dose levels of COR388 HCl in subjects with probable

dementia
  • 43 views
  • 08 Dec, 2020
  • 1 location
Featured trial
A double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms over 26 weeks in postmenopausal women

The OASIS Study is evaluating an investigational, hormone-free medication to see if it may safely andeffectively reduce hot flashes associated with menopause

hot flashes
  • 0 views
  • 05 Apr, 2022
  • 1 location
Featured trial
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Oral Ozanimod As Induction Therapy For Moderately To Severely Active Crohn’s Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely

  • 32 views
  • 23 Nov, 2020
  • 1 location